The maze of treatments for hepatitis B

N Engl J Med. 2005 Jun 30;352(26):2743-6. doi: 10.1056/NEJMe058119.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use*
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Drug Resistance, Viral
  • Drug Therapy, Combination
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / isolation & purification
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Lamivudine / therapeutic use*
  • Organophosphonates / adverse effects
  • Organophosphonates / therapeutic use*
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins

Substances

  • Antiviral Agents
  • Hepatitis B e Antigens
  • Interferon alpha-2
  • Interferon-alpha
  • Organophosphonates
  • Recombinant Proteins
  • Lamivudine
  • Polyethylene Glycols
  • Adenine
  • peginterferon alfa-2a
  • adefovir dipivoxil